Texte intégral
Decentralized Procedure DK/H/2475/001/DC
Travoprost 40 micrograms/ml Preservative Free Eye drops, solution (active ingredient: Travoprost)
History of e-CTD sequences:
March 2015 Sequence Date of
submission DK AT BE BG DE EL ES FR IE LU NL PL PT UK Submission description 0001 March 2015 X X X X X X X X X X X X X X Submission of Validation sequence for the Initial MAA Submission 0000 December
2014 X X X X X X X X X X X X X X New application for Marketing Authorization
Documents relatifs
Profile comparison between Travoprost Timolol 0.04mg/ml – 5mg/ml eye drops solution preservative free and DUOTRAV reference products (ALCON) reveals similarity between the
Five clinical studies were conducted for DuoTrav 40 micrograms/mL + 5 mg/mL eye drops, solution (Alcon Laboratories) to support the efficacy and safety of the
A 6-week, double-masked, parallel-group study of the efficacy and safety of travoprost 0.004% compared with latanoprost 0:005%/timolol 0.5% in patients with primary
[LATANOPROST] 50 mcg/ml preservative free eye drops, solution is indicated for thereduction of elevated intraocular pressure in patients with open angle glaucoma and
[r]
The overall efficacy of the bimatoprost 0.03 %/timolol 0.5 % eye drops combination in the treatment of patients with open-angle glaucoma or ocular hypertension
[r]
[r]
